Navamedic ASA (OSL:NAVA)
Norway
· Delayed Price · Currency is NOK 22.90
+1.50 (7.01%)
Apr 1, 2025, 3:44 PM CET
Navamedic ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 531.44 | 512 | 382.14 | 278.44 | 209.88 | Upgrade
|
| Revenue Growth (YoY) | 3.80% | 33.98% | 37.24% | 32.67% | 11.19% | Upgrade
|
| Cost of Revenue | 322.56 | 312.94 | 218.62 | 166.7 | 139.54 | Upgrade
|
| Gross Profit | 208.88 | 199.05 | 163.52 | 111.74 | 70.34 | Upgrade
|
| Selling, General & Admin | 162.33 | 63.67 | 48.09 | 44.46 | 32.57 | Upgrade
|
| Other Operating Expenses | - | 83.82 | 63.75 | 49.12 | 39.03 | Upgrade
|
| Operating Expenses | 177.08 | 159.41 | 119.08 | 100.29 | 75.26 | Upgrade
|
| Operating Income | 31.8 | 39.64 | 44.45 | 11.46 | -4.93 | Upgrade
|
| Interest Expense | -18.98 | -7.77 | -0.61 | -2.5 | -2.71 | Upgrade
|
| Interest & Investment Income | - | 4.21 | 3.08 | 2.79 | 2.52 | Upgrade
|
| Earnings From Equity Investments | - | - | -1.1 | -3.19 | -4.53 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 5.94 | -9.24 | -5.52 | -6.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | -6.43 | 13.58 | -0.68 | -0.81 | Upgrade
|
| EBT Excluding Unusual Items | 12.82 | 35.59 | 50.15 | 2.36 | -16.6 | Upgrade
|
| Merger & Restructuring Charges | - | -16.06 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -8.7 | -7.64 | - | - | Upgrade
|
| Asset Writedown | -7.66 | - | - | - | - | Upgrade
|
| Pretax Income | 5.16 | 10.83 | 42.51 | 2.36 | -16.6 | Upgrade
|
| Income Tax Expense | 3.87 | 7.53 | 13.07 | 1.74 | -0.14 | Upgrade
|
| Earnings From Continuing Operations | 1.29 | 3.3 | 29.43 | 0.62 | -16.46 | Upgrade
|
| Net Income | 1.29 | 3.3 | 29.43 | 0.62 | -16.46 | Upgrade
|
| Net Income to Common | 1.29 | 3.3 | 29.43 | 0.62 | -16.46 | Upgrade
|
| Net Income Growth | -60.96% | -88.77% | 4662.46% | - | - | Upgrade
|
| Shares Outstanding (Basic) | - | 17 | 17 | 16 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | - | 18 | 17 | 16 | 14 | Upgrade
|
| Shares Change (YoY) | - | 3.47% | 3.60% | 13.61% | 23.54% | Upgrade
|
| EPS (Basic) | - | 0.19 | 1.75 | 0.04 | -1.14 | Upgrade
|
| EPS (Diluted) | - | 0.19 | 1.73 | 0.04 | -1.14 | Upgrade
|
| EPS Growth | - | -89.13% | 4459.36% | - | - | Upgrade
|
| Free Cash Flow | 38.36 | -0.02 | 15.69 | -2.02 | -3.35 | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | 0.92 | -0.12 | -0.23 | Upgrade
|
| Gross Margin | 39.30% | 38.88% | 42.79% | 40.13% | 33.51% | Upgrade
|
| Operating Margin | 5.98% | 7.74% | 11.63% | 4.11% | -2.35% | Upgrade
|
| Profit Margin | 0.24% | 0.65% | 7.70% | 0.22% | -7.84% | Upgrade
|
| Free Cash Flow Margin | 7.22% | -0.00% | 4.11% | -0.73% | -1.60% | Upgrade
|
| EBITDA | 46.55 | 49.16 | 49.62 | 16.15 | -2.76 | Upgrade
|
| EBITDA Margin | 8.76% | 9.60% | 12.99% | 5.80% | -1.32% | Upgrade
|
| D&A For EBITDA | 14.76 | 9.52 | 5.18 | 4.69 | 2.16 | Upgrade
|
| EBIT | 31.8 | 39.64 | 44.45 | 11.46 | -4.93 | Upgrade
|
| EBIT Margin | 5.98% | 7.74% | 11.63% | 4.11% | -2.35% | Upgrade
|
| Effective Tax Rate | 74.98% | 69.50% | 30.76% | 73.79% | - | Upgrade
|
| Revenue as Reported | - | 512 | 382.14 | 278.44 | 209.88 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.